17.700
+0,28%
2026-10-19
Fundamental Analysis
67 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +23.8% | +186.7% | 2 / 3 | +39.6% | +8.69 pp | -7.11 pp | +6.4% | 0.00 | 9.77 | 12,3 | +39,6% | 6,9 | +23,8% | 9.77 | 13.03 | −25,0% |
| Pts | 4 | 12 | 8 | 12 | 12 | 0 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 17.700 (close price on 2026-10-19)EPS (TTM): 1.811
Financial charts
1.Revenue & growth
VND bn12,3Q2/26
1.Revenue & growth
VND bn12,3Q2/26
2.Profit & growth
VND bn6,86Q2/26
3.Profit mix (Penman)
VND bn29,0Q2/26
4.Margins & cost structure
%33.7%Q2/26
5.Returns & cash cycle
% · days3.0%Q2/26
6.Earnings quality & cash
VND bn-1,03Q2/26
7.Asset structure
VND bn381Q2/26
8.Funding & debt health
VND bn · times381Q2/26
9.Revenue backlog
VND bn0,14Q2/26
10.Valuation
times · %9,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %536Q2/26
Adjusted EPS growth, latest quarter
23.8%
Average adjusted EPS growth, 3 quarters
-2.7%
averaged over 2 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26